Weiguo Lü

687 total citations
25 papers, 403 citations indexed

About

Weiguo Lü is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Weiguo Lü has authored 25 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Weiguo Lü's work include Cervical Cancer and HPV Research (5 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Weiguo Lü is often cited by papers focused on Cervical Cancer and HPV Research (5 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Weiguo Lü collaborates with scholars based in China, United States and Germany. Weiguo Lü's co-authors include Huaizeng Chen, Xing Xie, Xing Xie, Yunfeng Fu, Feng Ye, Xing Xie, Feng Ye, Bei Cheng, Yan Yu and Qi Cheng and has published in prestigious journals such as Journal of Clinical Oncology, Life Sciences and Gynecologic Oncology.

In The Last Decade

Weiguo Lü

23 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiguo Lü China 10 169 133 126 75 60 25 403
Anna Hester Germany 12 115 0.7× 174 1.3× 52 0.4× 97 1.3× 129 2.1× 42 437
Huaiwu Lu China 12 186 1.1× 221 1.7× 75 0.6× 130 1.7× 85 1.4× 54 492
Jia Gao China 13 59 0.3× 178 1.3× 87 0.7× 120 1.6× 39 0.7× 25 407
Manuel Debald Germany 11 190 1.1× 182 1.4× 48 0.4× 183 2.4× 37 0.6× 23 500
Jole Ventriglia Italy 13 369 2.2× 111 0.8× 83 0.7× 125 1.7× 128 2.1× 36 547
Radosław Charkiewicz Poland 13 73 0.4× 197 1.5× 128 1.0× 132 1.8× 106 1.8× 36 473
Şeyda Karaveli Türkiye 10 56 0.3× 187 1.4× 82 0.7× 76 1.0× 50 0.8× 34 385
Yanfeng Liu China 11 163 1.0× 242 1.8× 53 0.4× 115 1.5× 56 0.9× 41 486
S.F. Yim Hong Kong 11 97 0.6× 268 2.0× 110 0.9× 176 2.3× 42 0.7× 19 519
Baoen Shan China 15 173 1.0× 296 2.2× 29 0.2× 158 2.1× 67 1.1× 46 516

Countries citing papers authored by Weiguo Lü

Since Specialization
Citations

This map shows the geographic impact of Weiguo Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Lü more than expected).

Fields of papers citing papers by Weiguo Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiguo Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Lü. The network helps show where Weiguo Lü may publish in the future.

Co-authorship network of co-authors of Weiguo Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Weiguo Lü. A scholar is included among the top collaborators of Weiguo Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiguo Lü. Weiguo Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Fei, Peter Hillemanns, Hongjie Ruan, et al.. (2025). Photodynamic therapy for high-grade squamous intraepithelial lesions: A randomized controlled trial. Med. 6(12). 100851–100851.
2.
Lü, Weiguo & Qishan Chen. (2024). Molecular Mechanisms of Nitrogen-Fixing Symbiosis in Fabaceae. 2 indexed citations
3.
Chen, Zhuojun, Y. Li, Weiguo Lü, et al.. (2024). Feasibility study of CMOS sensors in 55 nm process for tracking. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 1069. 169905–169905.
4.
Zheng, Fang, Kelie Chen, Yu Shi, et al.. (2023). PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway. Journal of Experimental & Clinical Cancer Research. 42(1). 295–295. 13 indexed citations
5.
Huang, Wei, Shu Yang, Yu‐Shan Cheng, et al.. (2022). Terfenadine resensitizes doxorubicin activity in drug-resistant ovarian cancer cells via an inhibition of CaMKII/CREB1 mediated ABCB1 expression. Frontiers in Oncology. 12. 1068443–1068443. 6 indexed citations
6.
Wan, Xiaoyun, et al.. (2021). Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas. BMC Cancer. 21(1). 1095–1095. 5 indexed citations
7.
Chen, Fengye, Chen Sun, Zengqi Yue, et al.. (2021). Screening ovarian cancers with Raman spectroscopy of blood plasma coupled with machine learning data processing. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 265. 120355–120355. 30 indexed citations
8.
Chen, Qin, Haiyan Shi, Weiguo Lü, & Bingjian Lü. (2018). Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas. European Journal of Obstetrics & Gynecology and Reproductive Biology. 230. 85–89. 9 indexed citations
9.
Fu, Yunfeng, et al.. (2012). Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer. Journal of obstetrics and gynaecology research. 38(4). 651–657. 84 indexed citations
10.
Chen, Xiaoduan, Haiyan Shi, Weiguo Lü, & Jiale Qin. (2011). [Histological evaluation of cervical carcinomas in FIGO stage Ib2/IIa after neoadjuvant chemotherapy].. PubMed. 40(3). 173–6. 1 indexed citations
11.
Li, Ying, Feng Ye, Xinyu Wang, et al.. (2010). Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive. Gynecologic Oncology. 120(1). 73–83. 9 indexed citations
12.
Ye, Jing, et al.. (2010). Risk factors triage on high-risk human papillomavirus testing screening.. PubMed. 20(8). 1374–80. 1 indexed citations
13.
Lü, Weiguo, Liwei Sun, Xiuqing Zhang, & Sun Jun-she. (2010). Properties of Glutamate Decarboxylase of Aspergillus oryzae and Its Application for Biotransformation of Glutamate into gamma-Aminobutyric Acid. 174. 1–5. 2 indexed citations
14.
Hu, Ying, et al.. (2009). HPV16 E6-Induced and E6AP-Dependent Inhibition of the Transcriptional Coactivator hADA3 in Human Cervical Carcinoma Cells. Cancer Investigation. 27(3). 298–306. 9 indexed citations
15.
Ye, Feng, et al.. (2009). Evaluation of immune inhibitory cytokine profiles in epithelial ovarian carcinoma. Journal of obstetrics and gynaecology research. 35(2). 212–218. 29 indexed citations
16.
Zhang, Jianping, et al.. (2005). [Tumor lymphangiogenesis in cervical squamous cell carcinoma and its clinical significance].. PubMed. 85(22). 1551–4. 2 indexed citations
17.
Lü, Weiguo, et al.. (2005). [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].. PubMed. 40(4). 239–42. 2 indexed citations
18.
Chen, Huaizeng, et al.. (2004). VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma. Gynecologic Oncology. 94(3). 630–635. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026